{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T15:56:19Z","timestamp":1775663779620,"version":"3.50.1"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770566"],"award-info":[{"award-number":["81770566"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NHC Key Laboratory of Echinococcosis Prevention and Control","award":["2021WZK1004"],"award-info":[{"award-number":["2021WZK1004"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000599"],"award-info":[{"award-number":["82000599"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Science & Technology Department of Sichuan Province Funding Project","award":["2023YFS0229"],"award-info":[{"award-number":["2023YFS0229"]}]},{"name":"Health Commission of the Tibet Autonomous Region","award":["311220432"],"award-info":[{"award-number":["311220432"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>\nBackground\n<\/jats:title>\n<jats:p>Non-alcoholic steatohepatitis (NASH)-associated hepatocellular carcinoma (HCC) has been emerging a predominant reason for liver transplantation (LT). The complexity of comorbidities in this population increases the possibility of poor transplant outcomes. The purpose of this study was to evaluate the differences in survival after transplantation among patients with NASH HCC and those with non-NASH HCC.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>\nMethod\n<\/jats:title>\n<jats:p>We conducted systematic searches of the PubMed, Embase, Web of Science, and Cochrane Library databases. To analyze the data, both fixed and random-effects models were employed to aggregate hazard ratios (HRs) along with 95% confidence intervals (CIs) for recurrence-free survival (RFS) and overall survival (OS) outcomes. This study is registered with PROSPERO as CRD42024578441.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>\nResults\n<\/jats:title>\n<jats:p>A total of seven studies were included in this study. This study revealed that there was no significant difference in OS between liver transplant recipients with NASH HCC and those with non-NASH HCC. The RFS of NASH HCC patients were significantly longer. The HRs were 0.70 (95% CI: 0.51-0.97, P\u2009=\u20090.03) for RFS and 0.88 (95% CI: 0.72-1.07, P\u2009=\u20090.21) for OS, respectively.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>\nConclusion\n<\/jats:title>\n<jats:p>This study indicates that patients with NASH HCC who undergo LT have comparable OS as those with non-NASH HCC, while NASH HCC was associated with increased RFS. However, further research in randomized trials is necessary to verify these results and address potential selection biases.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0317730","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T18:21:44Z","timestamp":1742408504000},"page":"e0317730","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Liver transplantation for NASH-related hepatocellular carcinoma versus non-NASH etiologies of hepatocellular carcinoma: A systematic review and meta-analysis"],"prefix":"10.1371","volume":"20","author":[{"given":"Kunlin","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6966-2665","authenticated-orcid":true,"given":"Wentao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"issue":"3","key":"pone.0317730.ref001","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"F Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"pone.0317730.ref002","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.livres.2024.03.002","article-title":"Targeting nuclear receptors for NASH\/MASH: From bench to bedside","volume":"8","author":"RA Sinha","year":"2024","journal-title":"Liver Res"},{"issue":"10290","key":"pone.0317730.ref003","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"EE Powell","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"pone.0317730.ref004","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamasurg.2022.7989","article-title":"Management of Hepatocellular Carcinoma: A Review","volume":"158","author":"ZJ Brown","year":"2023","journal-title":"JAMA Surg"},{"issue":"6","key":"pone.0317730.ref005","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1002\/hep.26986","article-title":"Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S","volume":"59","author":"RJ Wong","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"pone.0317730.ref006","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jhep.2018.02.012","article-title":"The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in waiting list composition","volume":"69","author":"G Crespo","year":"2018","journal-title":"J Hepatol"},{"issue":"3","key":"pone.0317730.ref007","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/jamasurg.2021.6781","article-title":"Impact of Portable Normothermic Blood-Based Machine Perfusion on Outcomes of Liver Transplant: The OCS Liver PROTECT Randomized Clinical Trial","volume":"157","author":"JF Markmann","year":"2022","journal-title":"JAMA Surg"},{"key":"pone.0317730.ref008","article-title":"New Scenarios in Liver Transplantation for Hepatocellular Carcinoma","author":"E Mauro","year":"2024","journal-title":"Liver Int"},{"issue":"17","key":"pone.0317730.ref009","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.3390\/cancers16173059","article-title":"Challenges in Liver Transplantation for Hepatocellular Carcinoma: A Review of Current Controversies","volume":"16","author":"E Mauro","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"6","key":"pone.0317730.ref010","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/hep.28123","article-title":"Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009","volume":"62","author":"ZM Younossi","year":"2015","journal-title":"Hepatology"},{"issue":"7","key":"pone.0317730.ref011","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/apt.14937","article-title":"Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases","volume":"48","author":"JG Stine","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"pone.0317730.ref012","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/lt.24764","article-title":"Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma","volume":"23","author":"SM Lewin","year":"2017","journal-title":"Liver Transpl"},{"issue":"7","key":"pone.0317730.ref013","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","article-title":"Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort","volume":"70","author":"TG Simon","year":"2021","journal-title":"Gut"},{"issue":"10","key":"pone.0317730.ref014","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/lt.24507","article-title":"Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma","volume":"22","author":"K Young","year":"2016","journal-title":"Liver Transpl"},{"issue":"2","key":"pone.0317730.ref015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/MEG.0000000000001270","article-title":"High incidence of hepatocellular carcinoma and postoperative complications in patients with nonalcoholic steatohepatitis as a primary indication for deceased liver transplantation","volume":"31","author":"B Kern","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"11","key":"pone.0317730.ref016","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1097\/TP.0000000000003575","article-title":"Sex-based Disparities in Hepatocellular Carcinoma Recurrence After Liver Transplantation","volume":"105","author":"G Cullaro","year":"2021","journal-title":"Transplantation"},{"issue":"4","key":"pone.0317730.ref017","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.hpb.2021.08.943","article-title":"Outcomes of liver transplantation for nonalcoholic steatohepatitis-associated hepatocellular carcinoma","volume":"24","author":"ML Holzner","year":"2022","journal-title":"HPB (Oxford)"},{"key":"pone.0317730.ref018","doi-asserted-by":"crossref","first-page":"10175","DOI":"10.3389\/ti.2022.10175","article-title":"Reduced Rates of Post-Transplant Recurrent Hepatocellular Carcinoma in Non-Alcoholic Steatohepatitis: A Propensity Score Matched Analysis","volume":"35","author":"R Lamm","year":"2022","journal-title":"Transpl Int"},{"issue":"5","key":"pone.0317730.ref019","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.hpb.2023.01.019","article-title":"Outcomes of liver transplantation in non-alcoholic steatohepatitis (NASH) versus non-NASH associated hepatocellular carcinoma","volume":"25","author":"L Rajendran","year":"2023","journal-title":"HPB (Oxford)"},{"issue":"4","key":"pone.0317730.ref020","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/TP.0000000000002043","article-title":"Liver Transplantation for NASH-Related Hepatocellular Carcinoma Versus Non-NASH Etiologies of Hepatocellular Carcinoma","volume":"102","author":"EM Sadler","year":"2018","journal-title":"Transplantation"},{"issue":"3","key":"pone.0317730.ref021","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/liv.14002","article-title":"Metabolic factors affecting hepatocellular carcinoma in steatohepatitis","volume":"39","author":"A Zarrinpar","year":"2019","journal-title":"Liver Int"},{"issue":"1","key":"pone.0317730.ref022","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12876-021-01786-6","article-title":"Impact of donor age on liver transplant outcomes in patients with hepatocellular carcinoma: analysis of the SRTR database","volume":"21","author":"J Zhou","year":"2021","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"pone.0317730.ref023","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jhep.2019.04.011","article-title":"Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study","volume":"71","author":"D Haldar","year":"2019","journal-title":"J Hepatol"},{"issue":"10","key":"pone.0317730.ref024","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1007\/s10620-017-4684-x","article-title":"Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes","volume":"62","author":"G Cholankeril","year":"2017","journal-title":"Dig Dis Sci"},{"issue":"3","key":"pone.0317730.ref025","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/hep.30858","article-title":"Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver Disease","volume":"71","author":"JD Yang","year":"2020","journal-title":"Hepatology"},{"issue":"1","key":"pone.0317730.ref026","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.dld.2019.08.022","article-title":"Hepatitis C remains leading indication for listings and receipt of liver transplantation for hepatocellular carcinoma","volume":"52","author":"AK Singal","year":"2020","journal-title":"Dig Liver Dis"},{"issue":"1","key":"pone.0317730.ref027","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jceh.2019.06.007","article-title":"Nonalcoholic Steatohepatitis Becomes the Leading Indication for Liver Transplant Registrants Among US Adults Born Between 1945 and 1965","volume":"10","author":"F Shirazi","year":"2020","journal-title":"Journal of Clinical and Experimental Hepatology"},{"issue":"11","key":"pone.0317730.ref028","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41395-018-0088-6","article-title":"NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances","volume":"113","author":"M Noureddin","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"pone.0317730.ref029","doi-asserted-by":"crossref","first-page":"e006971","DOI":"10.1136\/bmjopen-2014-006971","article-title":"Time-varying impact of comorbidities on mortality after liver transplantation: a national cohort study using linked clinical and administrative data","volume":"5","author":"C Tovikkai","year":"2015","journal-title":"BMJ Open"},{"issue":"31","key":"pone.0317730.ref030","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.3748\/wjg.v18.i31.4145","article-title":"A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis C virus patients with hepatocellular carcinoma","volume":"18","author":"R Hernandez-Alejandro","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"3","key":"pone.0317730.ref031","doi-asserted-by":"crossref","first-page":"594-601.e1","DOI":"10.1016\/j.cgh.2014.08.013","article-title":"Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population","volume":"13","author":"S Mittal","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"pone.0317730.ref032","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.jhep.2020.07.026","article-title":"Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma","volume":"73","author":"B Sangro","year":"2020","journal-title":"J Hepatol"},{"issue":"7680","key":"pone.0317730.ref033","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature24302","article-title":"Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity","volume":"551","author":"S Shalapour","year":"2017","journal-title":"Nature"},{"issue":"11","key":"pone.0317730.ref034","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.3390\/v14112427","article-title":"Higher Risk of Tumor Recurrence in NASH-Related Hepatocellular Carcinoma Following Curative Resection","volume":"14","author":"S-C Chien","year":"2022","journal-title":"Viruses"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0317730","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T18:22:36Z","timestamp":1742408556000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0317730"}},"subtitle":[],"editor":[{"given":"Yun-Wen","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0317730","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,19]]}}}